Moderna Inc (MRNA)
$65.63 1.53 (2.28%)
14:45 EDT MRNA Stock Quote Delayed 30 Minutes
Previous Close $67.16
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 4.27M
Day's Range 63.64 - 66.77
52-Week Range 13.53 - 95.21
Dividend & Yield N/A (N/A)
MRNA Stock Predictions, Articles, and Moderna Inc News
- From InvestorPlace
- From the Web
During this pandemic, Robinhood earned a reputation for being a conduit of irrational trading. However, many of the hot stocks featured on the platform are surprisingly viable.
Canada just ordered 20 million doses of Moderna’s Covid-19 vaccine. That’s excellent news for anyone who owns MRNA stock, Canadians included.
MRNA stock is up 25% since early September on renewed hope the company gets its Covid-19 vaccine through clinical trials by November.
Moderna looks like it has a winner with its Covid-19 vaccine. MRNA stock could make $35 billion if it delivers 1 billion doses, making its $26 billion market cap look cheap.
While airlines are still plenty of volatility, I’d use the weakness to pick up "blood in the street" opportunities like JBLU stock.
Moderna’s R&D day was a non-event, while upcoming clinical data posts may re-ignite MRNA stock buying.
MRNA stock is rallying Thursday on news Moderna will wrap up its late-stage trials by the end of the year. Here's why it matters.
With the race to find an effective vaccine tightening, MRNA stock just might have the inside lane due to lingering question marks about competing vaccine types. If so, Moderna can also do much good in addressing racial conflict in America.
By Thomas Niel
Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)
The pandemic shows no signs of slowing, it's time to use any signs of weakness in coronavirus stocks as a buying opportunity.
By Thomas Niel
Those who bought MRNA stock may be cashing out. But with risk/return still in your favor, taking a small position may be worthwhile.
Robinhood stocks that have a strong growth outlook and have presence in sectors that are in the limelight. These stocks are potential outperformers.
With plenty of support from the Trump Administration, a bullish analyst, and nearing Phase 3 trial data, MRNA stock could explode higher.
Yes, Moderna is advanced, relative to many rivals, in its efforts to bring a Covid-19 vaccine to market. However, the combination of the gravity of this situation – industries, jobs and most importantly, human lives, hang in the balance – and the timeline of getting a treatment to market make for a situation where upside in MRNA stock is unlikely to be linear.
By Joel Baglole
Pharmaceutical company Moderna is at the forefront of the global race to develop a vaccine against Covid-19. We could know as early as October whether Moderna's vaccine will be given the green light from regulators, and the company is already scaling up production to meet demand. Investors would be smart to buy MRNA shares now and ride them higher in the coming months.
A Roku earnings preview, along with Disney, Square and Moderna were our top stock trades from Wednesday. That said, let's look at the charts.
Navellier RatingsPowered by Portfolio Grader